A detailed history of First Republic Investment Management, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 4,129 shares of BNTX stock, worth $523,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,129
Previous 4,561 9.47%
Holding current value
$523,887
Previous $492,000 8.94%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$98.5 - $125.08 $42,552 - $54,034
-432 Reduced 9.47%
4,129 $448,000
Q2 2023

Jul 28, 2023

SELL
$102.58 - $129.66 $109,247 - $138,087
-1,065 Reduced 18.93%
4,561 $492,000
Q1 2023

May 11, 2023

SELL
$122.57 - $153.67 $41,183 - $51,633
-336 Reduced 5.64%
5,626 $700,000
Q4 2022

Feb 13, 2023

BUY
$118.43 - $186.05 $42,634 - $66,978
360 Added 6.43%
5,962 $895,000
Q3 2022

Nov 03, 2022

SELL
$127.65 - $183.11 $152,031 - $218,084
-1,191 Reduced 17.53%
5,602 $756,000
Q2 2022

Aug 16, 2022

BUY
$123.25 - $186.24 $14,420 - $21,790
117 Added 1.75%
6,793 $1.01 Million
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $129,153 - $237,182
1,023 Added 18.1%
6,676 $1.14 Million
Q4 2021

Feb 09, 2022

SELL
$216.64 - $362.52 $5.82 Million - $9.74 Million
-26,862 Reduced 82.61%
5,653 $1.46 Million
Q3 2021

Nov 12, 2021

BUY
$205.93 - $447.23 $3.27 Million - $7.1 Million
15,869 Added 95.33%
32,515 $8.88 Million
Q2 2021

Aug 16, 2021

BUY
$113.32 - $241.49 $111,620 - $237,867
985 Added 6.29%
16,646 $3.73 Million
Q1 2021

May 14, 2021

SELL
$85.73 - $119.5 $78,528 - $109,462
-916 Reduced 5.53%
15,661 $1.71 Million
Q4 2020

Feb 16, 2021

BUY
$72.71 - $129.54 $127,242 - $226,695
1,750 Added 11.8%
16,577 $1.35 Million
Q3 2020

Nov 12, 2020

BUY
$57.81 - $104.17 $267,486 - $481,994
4,627 Added 45.36%
14,827 $1.03 Million
Q2 2020

Aug 13, 2020

BUY
$38.58 - $66.74 $393,516 - $680,748
10,200 New
10,200 $681,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $30.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.